Evidence map›Paper›PMID 35517816›Full record

ArticleFrontiers in pharmacology2022

Anti-Apoptosis of Podocytes and Pro-Apoptosis of Mesangial Cells for Telmisartan in Alleviating Diabetic Kidney Injury.

Xin Wei, Yabin Ma, Ya Li, Wenzhao Zhang, Yuting Zhong, Yue Yu, Li-Chao Zhang, Zhibin Wang, Ye Tu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Unveiling the Role of MgMolecules (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. The role of PI3K/Akt signaling pathway in chronic kidney disease.International urology and nephrology · 2024
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Xin WeiDepartment of Clinical Pharmacy, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yabin MaDepartment of Pharmacy, Shanghai East Hospital, Tongji University, Shanghai, China.
Ya LiDepartment of Clinical Pharmacy, Clinical Trial Center, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
Wenzhao ZhangDepartment of Critical Care Medicine, School of Anesthesiology, Naval Medical University, Shanghai, China.
Yuting ZhongDepartment of Pharmacy, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, China.
Yue YuInstitute of Vascular Disease, Shanghai TCM-Integrated Hospital, Shanghai, China.
Li-Chao ZhangDepartment of Pharmacy, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, China.
Zhibin WangDepartment of Critical Care Medicine, School of Anesthesiology, Naval Medical University, Shanghai, China.
Ye TuDepartment of Pharmacy, Shanghai East Hospital, Tongji University, Shanghai, China.
Shanghai East Hospital · CNShanghai Traditional Chinese Medicine Hospital · CNIntegrated Chinese Medicine (China) · CNShandong Provincial QianFoShan Hospital · CNXinHua Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Podocytes damage and mesangial cells expansion are two important pathological manifestations of glomerular injury in early diabetes. Telmisartan, as an angiotensin type 1 (AT

Indexed as

apoptosisdiabetic kidney diseasemesangial cellspodocytes (MeSH: D050199)telmisartan (PubChem CID: 65

Identifiers

PMID35517816
PMCPMC9061946
OpenAlexW4224307205

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.